about
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsTranscription factor regulation of pancreatic organogenesis, differentiation and maturationDynamic distribution of claudin proteins in pancreatic epithelia undergoing morphogenesis or neoplastic transformationMesenchymal stem cell therapy in type 2 diabetes mellitus.Predicting pancreas cell fate decisions and reprogramming with a hierarchical multi-attractor model.Requirement for Pdx1 in specification of latent endocrine progenitors in zebrafish.OASIS/CREB3L1 induces expression of genes involved in extracellular matrix production but not classical endoplasmic reticulum stress response genes in pancreatic beta-cells.Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy.Connective tissue growth factor acts within both endothelial cells and beta cells to promote proliferation of developing beta cells.Gli-similar proteins: their mechanisms of action, physiological functions, and roles in disease.Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.Stem cell-based approaches for the treatment of diabetes.Islet organogenesis, angiogenesis and innervation.Directed differentiation of progenitor cells towards an islet-cell phenotype.Differentiation into Endoderm Lineage: Pancreatic differentiation from Embryonic Stem Cells.Novel genes underlying beta cell survival in metabolic stress.Pancreas β cell regeneration and type 1 diabetes (Review).Pancreatic regeneration: basic research and gene regulation.Threshold-Dependent Cooperativity of Pdx1 and Oc1 in Pancreatic Progenitors Establishes Competency for Endocrine Differentiation and β-Cell Function.Development and regeneration in the endocrine pancreasGLIS1-3: emerging roles in reprogramming, stem and progenitor cell differentiation and maintenance.The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes.
P2860
Q26752205-B207A91A-82DF-47C4-8317-C6E5ADC5E09EQ28083955-6513400A-E9C4-48CE-9CCA-F18C6742E315Q28507165-F914D451-9E28-44B1-B1BA-65367954F636Q33691629-015030D2-1B5F-4C3F-A2BA-8D3781860F47Q33851580-5788E564-401B-4FAB-AD28-8AFBAEC8A6D1Q34060685-BC7B46FB-9B75-4B7C-BDAD-E4B304364F27Q34132320-91F17AAD-364A-4F9C-B426-A97735F16F5AQ34485165-61243AC1-46E7-40EE-BEB0-AFF487B21264Q35217006-99C540CE-826B-41E3-8B0F-D6E9A49A4F4DQ37237607-62394276-2E3F-4B4E-9D98-D9FD370EF7EFQ37802776-82728AD6-352D-4BCF-961A-D2BB7EEFA227Q37895918-B3329B09-36C7-4B5D-ABFC-E9D0D48DCA19Q37945703-9569B1FF-EA5B-4A14-B3B4-5D5A07E64A24Q38106715-5C76C9AB-BDE3-4C8D-BCD1-12F9BB0C3965Q38168213-56E51D44-31B9-4002-961D-3086DBE8F935Q38317872-369560EC-E1BD-4259-BE52-28BC04F19E49Q38350555-6927D066-A467-4599-96D5-6966EC169044Q38543237-A4B14E41-17BD-4D5A-8C42-9CF2C3B75D0AQ42564616-247FC15B-43DA-4A25-B5C1-86A5F8EFBC17Q42720344-98999033-4B14-4C48-B566-16E91912E5FBQ47618990-D7C5ACCF-5D2F-4F55-BC29-8D3B99DE700AQ52648066-30C0CEDF-761C-4EFE-AE90-9928C74CC85C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pancreas cell fate.
@en
Pancreas cell fate.
@nl
type
label
Pancreas cell fate.
@en
Pancreas cell fate.
@nl
prefLabel
Pancreas cell fate.
@en
Pancreas cell fate.
@nl
P2860
P356
P1476
Pancreas cell fate.
@en
P2093
Maureen Gannon
Michelle A Guney
P2860
P304
P356
10.1002/BDRC.20156
P577
2009-09-01T00:00:00Z